Paper41220940
A comparison of clinical guidelines, treatment characteristics and outcomes in small cell lung cancer between East Asia and Europe/North America.
Chiang CL and 9 others. Front Oncol, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. A comparison of clinical guidelines, treatment characteristics and outcomes in small cell lung cancer between East Asia and Europe/North America. Papers, record 41220940. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41220940
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A comparison of clinical guidelines, treatment characteristics and outcomes in small cell lung cancer between East Asia and Europe/North America.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References107
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33828968 | Treatment Outcomes of 9,994 Patients With Extensive-Disease Small-Cell Lung Cancer From a Retrospective Nationwide Population-Based Cohort in the Korean HIRA Database. | Front Oncol | 2021 | https://conductscience.org/library/papers/33828968 | PubMed |
| 2 | 38992123 | Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial. | Nat Med | 2024 | https://conductscience.org/library/papers/38992123 | PubMed |
| 3 | 33864941 | Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆. | Ann Oncol | 2021 | https://conductscience.org/library/papers/33864941 | PubMed |
| 4 | 39268857 | Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer. | N Engl J Med | 2024 | https://conductscience.org/library/papers/39268857 | PubMed |
| 5 | 33492362 | Race and Pharmacogenomics-Personalized Medicine or Misguided Practice? | JAMA | 2021 | https://conductscience.org/library/papers/33492362 | PubMed |
| 6 | 21714641 | Reduced lung-cancer mortality with low-dose computed tomographic screening. | N Engl J Med | 2011 | https://conductscience.org/library/papers/21714641 | PubMed |
| 7 | 24828667 | Small-cell lung cancers in patients who never smoked cigarettes. | J Thorac Oncol | 2014 | https://conductscience.org/library/papers/24828667 | PubMed |
| 8 | 29770597 | Comparison and discussion of the treatment guidelines for small cell lung cancer. | Thorac Cancer | 2018 | https://conductscience.org/library/papers/29770597 | PubMed |
| 9 | 37037178 | Identification of inflamed-phenotype of small cell lung cancer leading to the efficacy of anti-PD-L1 antibody and chemotherapy. | Lung Cancer | 2023 | https://conductscience.org/library/papers/37037178 | PubMed |
| 10 | 37150311 | Novel therapeutic strategies for recurrent SCLC. | Crit Rev Oncol Hematol | 2023 | https://conductscience.org/library/papers/37150311 | PubMed |
| 11 | 37504325 | Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer. | Curr Oncol | 2023 | https://conductscience.org/library/papers/37504325 | PubMed |
| 12 | 34047192 | Race and ethnicity representation in clinical trials: findings from a literature review of Phase I oncology trials. | Future Oncol | 2021 | https://conductscience.org/library/papers/34047192 | PubMed |
| 13 | 32959954 | Prognostic value of pretreatment smoking status for small cell lung cancer: A meta-analysis. | Thorac Cancer | 2020 | https://conductscience.org/library/papers/32959954 | PubMed |
| 14 | 37054974 | Whole-Section Landscape Analysis of Molecular Subtypes in Curatively Resected Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Significance. | Mod Pathol | 2023 | https://conductscience.org/library/papers/37054974 | PubMed |
| 15 | 37460438 | [Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2023 edition)]. | Zhonghua Zhong Liu Za Zhi | 2023 | https://conductscience.org/library/papers/37460438 | PubMed |
| 16 | 35220975 | Clinical characteristics and patient outcomes of molecular subtypes of small cell lung cancer (SCLC). | World J Surg Oncol | 2022 | https://conductscience.org/library/papers/35220975 | PubMed |
| 17 | 37098228 | Tarlatamab: New Star on the Horizon for Small-Cell Lung Cancer? | J Clin Oncol | 2023 | https://conductscience.org/library/papers/37098228 | PubMed |
| 18 | 17450263 | Survival of small-cell lung cancer and its determinants of outcome in Singapore. | Ann Acad Med Singap | 2007 | https://conductscience.org/library/papers/17450263 | PubMed |
| 19 | 33245986 | Clinicopathological features and prognostic analysis of 247 small cell lung cancer with limited-stage after surgery. | Hum Pathol | 2021 | https://conductscience.org/library/papers/33245986 | PubMed |
| 20 | 34902832 | Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2021 | https://conductscience.org/library/papers/34902832 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42762420 | Tarlatamab in small cell lung cancer following platinum-based chemotherapy: subgroup analysis of Japanese patients from the DeLLphi-304 study. | Int J Clin Oncol | 2026 | https://conductscience.org/library/papers/42762420 | PubMed |
| 42366584 | Diagnostic Value of CCL2 and CCR2 in Pleural Effusion for Distinguishing Lung Cancer Histological Subtypes: A Retrospective Study. | Diagn Cytopathol | 2026 | https://conductscience.org/library/papers/42366584 | PubMed |
| 42183205 | Case Report: Neuroendocrine-marker-negative high-grade neuroendocrine carcinoma mimicking squamous cell carcinoma: an underrecognized diagnostic pitfall. | Front Immunol | 2026 | https://conductscience.org/library/papers/42183205 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41220940
GET https://conductscience.org/api/papers/v1/41220940/references?page=2